MGMT Promoter Methylation and Parathyroid Carcinoma

Show full item record



Permalink

http://hdl.handle.net/10138/306780

Citation

Storvall , S , Ryhänen , E , Heiskanen , I , Vesterinen , T , Bensch , F V , Schildt , J , Kytölä , S , Karhu , A , Arola , J & Schalin-Jäntti , C 2019 , ' MGMT Promoter Methylation and Parathyroid Carcinoma ' , Journal of the Endocrine Society , vol. 3 , no. 11 , pp. 2114–2122 . https://doi.org/10.1210/js.2019-00175

Title: MGMT Promoter Methylation and Parathyroid Carcinoma
Author: Storvall, Sara; Ryhänen, Eeva; Heiskanen, Ilkka; Vesterinen, Tiina; Bensch, Frank V.; Schildt, Jukka; Kytölä, Soili; Karhu, Auli; Arola, Johanna; Schalin-Jäntti, Camilla
Contributor: University of Helsinki, Endokrinologian yksikkö
University of Helsinki, HUS Abdominal Center
University of Helsinki, HUS Abdominal Center
University of Helsinki, HUSLAB
University of Helsinki, HUS Medical Imaging Center
University of Helsinki, HUS Medical Imaging Center
University of Helsinki, HUSLAB
University of Helsinki, University Management
University of Helsinki, HUSLAB
University of Helsinki, HUS Abdominal Center
Date: 2019-11
Language: eng
Number of pages: 9
Belongs to series: Journal of the Endocrine Society
ISSN: 2472-1972
URI: http://hdl.handle.net/10138/306780
Subject: 3122 Cancers
PARATHYROID CARCINOMA
treatment
MGMT promoter methylation
TEMOZOLOMIDE
3121 General medicine, internal medicine and other clinical medicine
3126 Surgery, anesthesiology, intensive care, radiology
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
untitled.pdf 262.5Kb PDF View/Open

This item appears in the following Collection(s)

Show full item record